Morgan Stanley is a stock, not an exchange-traded fund, so the central target is built from individual analyst price targets. I reviewed roughly 14 recent, attributed targets issued after the company's third-quarter 2026 earnings report, spanning approximately $190 to $262. The arithmetic mean of these targets is near $218, which rounds to the $220 central target used throughout this article.
Views are split. Bullish analysts include MS's Jefferies ($262) and UBS ($240), while Keefe Bruyette holds an Outperform rating with a $230 target and called the post-earnings pullback a "very attractive entry point," citing recurring-revenue exposure and "multi-pronged ability to capture AI wealth creation." Bank of America ($220), BMO Capital ($210), and Evercore ISI ($205) sit in the middle, while Wells Fargo ($217, Equal Weight) and RBC Capital ($195) are more cautious. Wells Fargo's Mike Mayo described the quarter as "very good but not great" and trimmed forward estimates on capital-markets caution.
The latest verified closing price for Morgan Stanley (MS) is about $181.44. Reaching the $220 average analyst price target implies upside of roughly 21%, a substantial move. The stock traded in a 52-week range of about $152.80 to $232.25 and fell sharply from its highs before stabilizing, which is why several analysts describe the current level as an improved risk-reward entry point rather than a stretched valuation.
Fundamentally, the company reported third-quarter EPS (earnings per share) of $3.03, about $0.10 above consensus, on revenue of roughly $20.34 billion. Wealth Management posted record revenue, pre-tax income, and net new assets (up 11%), while Institutional Securities revenue rose about 18% with equities revenue up roughly 41%. Return on tangible common equity reached 22.6%, a fifth consecutive quarter above 20%. A path toward $220 would likely require continued wealth-management inflows, sustained trading activity, and a stabilization of the valuation multiple from its current roughly 14x trailing P/E (price-to-earnings ratio).
The stock's recent sharp decline from above $230 toward the low-$180s created a gap that now acts as overhead supply. The $180–$185 zone has functioned as near-term support, while the $190–$195 area and the psychologically significant $200 level represent the first resistance zones on any recovery. A sustained move toward the $220 target would need to reclaim the $210–$215 range, which sits just below the calculated mean and is where several recent target cuts cluster.
Analyst price targets generally reflect a roughly 12-month research horizon, though individual firms differ. Investors should watch quarterly earnings and guidance, particularly wealth-management net new assets, Institutional Securities revenue, and return on tangible common equity; further analyst target revisions; interest-rate decisions; and the pace of M&A (mergers and acquisitions) and capital-raising activity, which directly drive the franchise's cyclical earnings.
AI Daily Buy/Sell Signals from Tickeron use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a name like MS, these signals can help traders spot shifting trends, monitor existing positions, and identify new opportunities more efficiently than manual chart review. Exploring the AI Daily Buy/Sell Signals can add a systematic layer to your own research.
Can Morgan Stanley stock reach $220? The $220 central target, derived from the average of about 14 verified analyst price targets spanning roughly $190 to $262, requires a substantial move of about 21% from the latest price near $181.44. The bull case rests on record wealth-management results, strong trading momentum, and a valuation that has reset after a steep correction. The bear case hinges on cyclical capital-markets risk and the downward estimate revisions several firms have already made. With targets spread across a $70 range, even professional analysts disagree meaningfully on the answer, and no outcome is guaranteed.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, MS has been closely correlated with GS. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if MS jumps, then GS could also see price increases.